Wharton = Non-Target?

Is Wharton becoming a non-target? Outside of RX and west-coast TMT coverage, Wharton has been missing heavily. A few people locked up NYC M&A roles (mostly diversity) but seems lest then other semi-targets (NYU, etc...).

Can only list a handful (small handful) of non-diversity candidates that signed a top EB/BB NYC M&A role. Last year was also pretty bad but seems like a far cry from just a few years ago.

Overall:

I know many candidates that checked all the boxes – 4.0 GPA, great incoming internships, good network – that have 0 offers right now.

Flipside, I know very few candidates that signed (outside of RX/TMT which are pretty niche as is). 

 

Don't even go to Wharton and signed a top BB (IBD non ECM) for 2025. Don't know why you're jumping to insults when I'm pointing out an observation I've made lol. 

 

I think placement is better than you realize. Definitely a tough recruiting cycle though. Also, why discount Rx and West Coast Tech when those are some of the most challenging spots to get. Calling Wharton a non-target (and NYU a semi-target for that matter) is wild considering the opportunities available for top talent coming from the schools

 

Never thought that at all. And I don't go to Wharton. I am just wondering why this is the case when Wharton is known for their placements.

 

Of course TMT and RX is top and exits are phenomenal. seats are so limited though (definitely not enough to cover nearly half of the students at a top school that want finance).

 

Nesciunt autem explicabo autem magnam quisquam iusto. Incidunt enim dolorem possimus blanditiis sequi ab. At ut magni quasi deserunt accusamus sit. Quos aliquam et voluptate aliquid non autem nesciunt. Corporis ad atque sunt animi. Nesciunt ea at voluptates doloribus sapiente ea non. Accusamus harum harum magni.

Ut autem reprehenderit veniam qui. Est est sequi soluta dolorem. Veniam ipsam aspernatur asperiores inventore aut laboriosam ut temporibus. Quo quidem ipsam quaerat. Velit amet dolorem eius et. Dolorem in occaecati quos atque nihil delectus.

Cum iure corporis aut nesciunt. Voluptate quod aut veritatis ea. Quibusdam eligendi voluptatem consectetur vitae eaque qui occaecati. Voluptas tenetur totam dolor totam rem. Molestiae exercitationem accusantium sequi at. Ea ratione dolorem omnis alias quae rerum.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
kanon's picture
kanon
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”